Anne Aries

887 total citations
21 papers, 718 citations indexed

About

Anne Aries is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anne Aries has authored 21 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anne Aries's work include Congenital heart defects research (4 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Pluripotent Stem Cells Research (2 papers). Anne Aries is often cited by papers focused on Congenital heart defects research (4 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Pluripotent Stem Cells Research (2 papers). Anne Aries collaborates with scholars based in France, Canada and United States. Anne Aries's co-authors include Mona Nemer, Pierre Paradis, Chantal Lefèbvre, Robert J. Schwartz, Steves Morin, Rachid Lahlil, Hiba Komati, Pierre Jeannesson, Franck Morceau and Philippe Hénon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular and Cellular Biology.

In The Last Decade

Anne Aries

20 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Aries France	13	460	232	119	101	65	21	718
Prachi Umbarkar United States	15	363 0.8×	302 1.3×	86 0.7×	100 1.0×	49 0.8×	22	706
Nagadhara Dronadula United States	16	358 0.8×	81 0.3×	116 1.0×	147 1.5×	51 0.8×	22	643
Claudia M. van Tiel Netherlands	19	426 0.9×	69 0.3×	114 1.0×	143 1.4×	16 0.2×	46	1.1k
Nadia Hedhli United States	13	596 1.3×	293 1.3×	160 1.3×	73 0.7×	20 0.3×	17	861
Alicia Zukas United States	9	170 0.4×	116 0.5×	153 1.3×	107 1.1×	29 0.4×	21	687
Shufang Zhao China	12	352 0.8×	265 1.1×	70 0.6×	76 0.8×	19 0.3×	23	634
Mélanie Lambert France	14	456 1.0×	107 0.5×	148 1.2×	46 0.5×	44 0.7×	28	802
Maarten Vanwildemeersch Sweden	5	378 0.8×	105 0.5×	58 0.5×	48 0.5×	32 0.5×	5	585
Nour‐Eddine Rhaleb United States	19	408 0.9×	207 0.9×	110 0.9×	48 0.5×	122 1.9×	39	963
Holger Summer Germany	10	324 0.7×	173 0.7×	44 0.4×	47 0.5×	41 0.6×	14	660

Countries citing papers authored by Anne Aries

Since Specialization

Citations

This map shows the geographic impact of Anne Aries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Aries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Aries more than expected).

Fields of papers citing papers by Anne Aries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Aries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Aries. The network helps show where Anne Aries may publish in the future.

Co-authorship network of co-authors of Anne Aries

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Aries. A scholar is included among the top collaborators of Anne Aries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Aries. Anne Aries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aries, Anne, Bernard Drénou, & Rachid Lahlil. (2025). Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives. International Journal of Molecular Sciences. 26(15). 7547–7547. 3 indexed citations

Aries, Anne, et al.. (2023). Development of a potency assay for CD34+ cell-based therapy. Scientific Reports. 13(1). 19665–19665. 5 indexed citations

Lahlil, Rachid, et al.. (2023). Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia. International Journal of Molecular Sciences. 24(23). 16671–16671. 2 indexed citations

Aries, Anne, et al.. (2023). Deciphering the Cardiovascular Potential of Human CD34+ Stem Cells. International Journal of Molecular Sciences. 24(11). 9551–9551. 4 indexed citations

Hénon, Philippe, et al.. (2022). Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe. Stem Cell Reviews and Reports. 18(5). 1614–1626. 7 indexed citations

Lahlil, Rachid, et al.. (2021). Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells. Biology. 10(4). 312–312.

Lahlil, Rachid, et al.. (2018). VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion. Stem Cell Reviews and Reports. 14(4). 510–524. 45 indexed citations

Adam, Frédéric, Abdel‐Majid Khatib, José J. López, et al.. (2015). Apelin: an antithrombotic factor that inhibits platelet function. Blood. 127(7). 908–920. 55 indexed citations

Aries, Anne, et al.. (2014). Ageing is a Risk Factor in Imatinib Mesylate Cardiotoxicity. European Journal of Heart Failure. 16(4). 367–376. 30 indexed citations

10.

Aries, Anne, et al.. (2014). Caspase-1 cleavage of transcription factor GATA4 and regulation of cardiac cell fate. Cell Death and Disease. 5(12). e1566–e1566. 28 indexed citations

11.

Yamak, Abir, Rana M. Temsah, Sophie Jeanne Cécile Caron, et al.. (2012). Cyclin D₂ rescues size and function of GATA4 haplo-insufficient hearts. American Journal of Physiology-Heart and Circulatory Physiology. 303(8). H1057–H1066. 17 indexed citations

12.

Nemer, Mona, Nassim Dali‐Youcef, Hao Wang, Anne Aries, & Pierre Paradis. (2006). Mechanisms of Angiotensin II‐Dependent Progression to Heart Failure. Novartis Foundation symposium. 274. 58–72. 8 indexed citations

13.

Wang, Jun, Pierre Paradis, Anne Aries, et al.. (2005). Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4. Molecular and Cellular Biology. 25(22). 9829–9844. 57 indexed citations

14.

Aries, Anne, Pierre Paradis, Chantal Lefèbvre, Robert J. Schwartz, & Mona Nemer. (2004). Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proceedings of the National Academy of Sciences. 101(18). 6975–6980. 245 indexed citations

15.

Aries, Anne, et al.. (2001). Purification of Human Recombinant GATA-1 from Bacteria: Implication for Protein-Protein Interaction Studies. Protein Expression and Purification. 23(3). 426–431. 4 indexed citations

16.

Morin, Steves, Pierre Paradis, Anne Aries, & Mona Nemer. (2001). Serum Response Factor-GATA Ternary Complex Required for Nuclear Signaling by a G-Protein-Coupled Receptor. Molecular and Cellular Biology. 21(4). 1036–1044. 94 indexed citations

17.

Jeannesson, Pierre, Rachid Lahlil, Benoı̂t Chénais, et al.. (1997). Anthracyclines as Tumor Cell Differentiating Agents: Effects on the Regulation of Erythroid Gene Expression. Leukemia & lymphoma. 26(5-6). 575–587. 31 indexed citations

18.

Morceau, Franck, Anne Aries, Rachid Lahlil, et al.. (1996). Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells. Biochemical Pharmacology. 51(6). 839–845. 35 indexed citations

19.

Aries, Anne, et al.. (1996). Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells. Blood. 87(7). 2885–2890. 19 indexed citations

20.

Trentesaux, Coralie, et al.. (1993). Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.. PubMed. 7(3). 452–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact